THIORIDAZINE HYDROCHLORIDE

Post-LOE

Wockhardt

ANDAORALCONCENTRATE

Approved

Jul 1983

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

THIORIDAZINE HYDROCHLORIDE by Wockhardt is clinical pharmacology the basic pharmacological activity of thioridazine is similar to that of other phenothiazines, but is associated with minimal extrapyramidal stimulation. Approved for schizophrenic patients. First approved in 1983.

Drug data last refreshed 8h ago

Mechanism of Action

CLINICAL PHARMACOLOGY The basic pharmacological activity of thioridazine is similar to that of other phenothiazines, but is associated with minimal extrapyramidal stimulation. However, thioridazine has been shown to prolong the QTc interval in a dose dependent fashion. This effect may increase the…

Indications (1)

schizophrenic patients

Worked on THIORIDAZINE HYDROCHLORIDE at Wockhardt? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.